CD8A and colon adenocarcinoma: These markers were used to characterize immune cells, including CD8+ T and CD4+ T cell, B cell, M1/M2 macrophage, monocyte, neutrophil, NK, tumor‐associated macrophage, and DC in STAD and COAD.